Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Connexins | 3 | 2019 | 357 | 1.640 |
Why?
|
| Keratitis | 2 | 2019 | 268 | 1.060 |
Why?
|
| Ichthyosis | 3 | 2024 | 60 | 0.920 |
Why?
|
| Turner Syndrome | 2 | 2021 | 130 | 0.900 |
Why?
|
| Genes, Lethal | 1 | 2019 | 242 | 0.660 |
Why?
|
| Respiratory Tract Fistula | 1 | 2018 | 26 | 0.660 |
Why?
|
| Protein Structure, Quaternary | 1 | 2019 | 436 | 0.630 |
Why?
|
| Failure to Thrive | 1 | 2018 | 136 | 0.620 |
Why?
|
| Dermatology | 3 | 2023 | 872 | 0.600 |
Why?
|
| Skin Diseases | 2 | 2016 | 1065 | 0.520 |
Why?
|
| Cosmetics | 2 | 2016 | 97 | 0.510 |
Why?
|
| Deafness | 1 | 2018 | 458 | 0.480 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 707 | 0.460 |
Why?
|
| Oximes | 1 | 2015 | 311 | 0.450 |
Why?
|
| Keratosis, Seborrheic | 1 | 2012 | 27 | 0.430 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2012 | 151 | 0.390 |
Why?
|
| Vitiligo | 1 | 2012 | 89 | 0.390 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 1121 | 0.330 |
Why?
|
| Imidazoles | 1 | 2015 | 1206 | 0.320 |
Why?
|
| Complementary Therapies | 1 | 2012 | 486 | 0.310 |
Why?
|
| Ichthyosis, Lamellar | 1 | 2024 | 11 | 0.240 |
Why?
|
| Cosmetic Techniques | 2 | 2016 | 135 | 0.210 |
Why?
|
| Nevus, Halo | 1 | 2020 | 6 | 0.190 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2019 | 19 | 0.180 |
Why?
|
| Tinea Capitis | 1 | 2019 | 12 | 0.180 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2020 | 40 | 0.180 |
Why?
|
| Models, Molecular | 2 | 2019 | 5456 | 0.160 |
Why?
|
| Pemphigus, Benign Familial | 1 | 2018 | 8 | 0.160 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2019 | 156 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 5535 | 0.160 |
Why?
|
| Thermodynamics | 1 | 2019 | 596 | 0.150 |
Why?
|
| Protein Stability | 1 | 2019 | 557 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 3523 | 0.140 |
Why?
|
| Syringoma | 1 | 2016 | 5 | 0.140 |
Why?
|
| Antimalarials | 1 | 2023 | 905 | 0.140 |
Why?
|
| Fibroadenoma | 1 | 2016 | 43 | 0.140 |
Why?
|
| Naltrexone | 1 | 2018 | 307 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2019 | 372 | 0.130 |
Why?
|
| Rheumatic Diseases | 1 | 2022 | 592 | 0.130 |
Why?
|
| Ectodermal Dysplasia | 1 | 2016 | 106 | 0.130 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 1150 | 0.130 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2016 | 108 | 0.120 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 2011 | 0.120 |
Why?
|
| Molecular Structure | 1 | 2018 | 1899 | 0.120 |
Why?
|
| Longevity | 1 | 2021 | 1070 | 0.120 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 562 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 966 | 0.110 |
Why?
|
| Epidermis | 1 | 2016 | 528 | 0.110 |
Why?
|
| Aromatherapy | 1 | 2012 | 4 | 0.110 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 1061 | 0.110 |
Why?
|
| Biological Products | 1 | 2021 | 860 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2022 | 1339 | 0.100 |
Why?
|
| Medicine, Ayurvedic | 1 | 2012 | 37 | 0.100 |
Why?
|
| Naphthoquinones | 1 | 2012 | 77 | 0.100 |
Why?
|
| Quality of Life | 2 | 2018 | 12804 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11524 | 0.100 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2012 | 71 | 0.100 |
Why?
|
| Clothing | 1 | 2012 | 92 | 0.100 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 5686 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 2016 | 894 | 0.090 |
Why?
|
| Humans | 22 | 2024 | 744343 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 977 | 0.080 |
Why?
|
| Mutation | 3 | 2019 | 29786 | 0.080 |
Why?
|
| Comorbidity | 1 | 2023 | 10388 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4149 | 0.080 |
Why?
|
| Education, Medical | 1 | 2020 | 1721 | 0.080 |
Why?
|
| Analgesics | 1 | 2015 | 1040 | 0.080 |
Why?
|
| Acupuncture Therapy | 1 | 2012 | 464 | 0.080 |
Why?
|
| Body Weight | 1 | 2018 | 4669 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2012 | 969 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2023 | 77449 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 2043 | 0.060 |
Why?
|
| Pandemics | 2 | 2023 | 8388 | 0.060 |
Why?
|
| Genotype | 1 | 2018 | 12951 | 0.060 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.050 |
Why?
|
| Psychometrics | 1 | 2012 | 3002 | 0.050 |
Why?
|
| Erythema | 1 | 2024 | 257 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5510 | 0.050 |
Why?
|
| Male | 8 | 2021 | 350118 | 0.050 |
Why?
|
| Middle Aged | 7 | 2020 | 213383 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25043 | 0.050 |
Why?
|
| Aminoquinolines | 1 | 2020 | 109 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2023 | 412 | 0.040 |
Why?
|
| Chromosomes, Human, Y | 1 | 2019 | 148 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2018 | 25625 | 0.040 |
Why?
|
| Massachusetts | 2 | 2021 | 8663 | 0.040 |
Why?
|
| Observer Variation | 1 | 2024 | 2593 | 0.040 |
Why?
|
| Infant | 1 | 2018 | 35136 | 0.040 |
Why?
|
| Adult | 7 | 2023 | 214055 | 0.030 |
Why?
|
| Acne Vulgaris | 1 | 2020 | 302 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2020 | 1619 | 0.030 |
Why?
|
| Female | 6 | 2021 | 380194 | 0.030 |
Why?
|
| Aged | 5 | 2021 | 163280 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3271 | 0.030 |
Why?
|
| Foot | 1 | 2016 | 527 | 0.030 |
Why?
|
| Psoriasis | 1 | 2020 | 898 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 63114 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 21683 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13695 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2023 | 2987 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2020 | 3528 | 0.020 |
Why?
|
| Students, Medical | 1 | 2020 | 1862 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 15540 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 19905 | 0.020 |
Why?
|
| Mental Health | 1 | 2019 | 3019 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2019 | 9146 | 0.020 |
Why?
|
| Animals | 1 | 2016 | 168757 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 56430 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57776 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 85781 | 0.010 |
Why?
|
| Child | 2 | 2020 | 77709 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 41006 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39050 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72290 | 0.010 |
Why?
|
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_